Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.3060
-0.0070
(-2.24%)
At close: February 24 at 5:35:27 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
52,980
75,843
114,609
142,266
Total Liabilities Net Minority Interest
31,567
33,550
39,057
41,431
Total Equity Gross Minority Interest
21,413
42,293
75,552
100,835
Total Capitalization
46,566
67,590
96,072
113,522
Common Stock Equity
21,413
42,293
75,552
100,835
Capital Lease Obligations
--
718
986
1,099
Net Tangible Assets
21,388.7350
42,292
9,941
12,324
Working Capital
45,422
63,253
39,738
37,117
Invested Capital
46,566
67,590
96,072
118,811
Tangible Book Value
21,388.7350
42,292
9,941
12,324
Total Debt
25,153
25,297
21,506
19,075
Net Debt
13,894
--
--
--
Share Issued
50,170.4980
50,100.4480
43,138.1850
37,030.3350
Ordinary Shares Number
50,170.4980
50,100.4480
43,138.1850
37,030.3350
12/31/2020 - 4/12/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TGNA.F Transgene SA
0.7030
0.00%
ALVAL.PA Valbiotis SA
1.3300
+3.91%
0NZU.IL Zealand Pharma A/S
706.50
-1.88%
ALVIO.PA Valerio Therapeutics Société anonyme
0.0539
+4.46%
TNG.PA Transgene SA
0.7200
+0.70%
ADOC.PA Adocia SA
4.8200
-2.43%
NANO.PA Nanobiotix S.A.
3.6180
+0.44%
GNFT.PA Genfit S.A.
3.6750
-0.68%
FYB.F Formycon AG
27.20
-8.72%
SPRO Spero Therapeutics, Inc.
0.8051
-3.12%